发明名称 1,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury
摘要 The present invention relates to compounds of formula I:; for use in treating pulmonary arterial hypertension and associated conditions, where R1, R2 and R3 are the same or different and signify hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; R4 signifies hydrogen, alkyl, -alkylaryl or -alkylheteroaryl; X signifies CH2, oxygen atom or sulphur atom; n is 1, 2 or 3, with the proviso that when n is 1, X is not CH2; and the individual (R)- and (S)-enantiomers or mixtures of enantiomers and pharmaceutically acceptable salts thereof.
申请公布号 US9604970(B2) 申请公布日期 2017.03.28
申请号 US201314441043 申请日期 2013.11.14
申请人 Bial-Portela & CA, S.A. 发明人 Soares Da Silva Patrício Manuel Vieira Araújo;Bonifácio Maria João Macedo Da Silva
分类号 A61K31/417;A61K31/4178;C07D405/04 主分类号 A61K31/417
代理机构 Conley Rose, P.C. 代理人 Conley Rose, P.C. ;Carroll Rodney B.
主权项 1. A method of treating pulmonary arterial hypertension comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I: wherein R1, R2 and R3 are the same or different and signify hydrogens, halogens, alkyl, alkylaryl, alkyloxy, hydroxy, nitro, amino, alkylcarbonylamino, alkylamino or dialkylamino group; R4 signifies hydrogen, alkyl, -alkylaryl or -alkylheteroaryl; X signifies CH2, oxygen atom or sulphur atom; n is 1, 2 or 3, with the proviso that when n is 1, X is not CH2; and the individual (R)- and (S)-enantiomers or mixtures of enantiomers and pharmaceutically acceptable salts thereof, optionally in combination with at least one other active pharmaceutical ingredient.
地址 S. Mamede do Coronado PT